Inhaled ethyl nitrite gas for persistent pulmonary hypertension of the newborn

Lancet

Volumn 360, Issue 9327, 2002, Pages 141-143

  Moya, Martin P ^a   Gow, Andrew J ^a   Califf, Robert M ^b   Goldberg, Ronald N ^a   Stamler, Jonathan S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL DERIVATIVE; NITRIC OXIDE; O NITROSOETHANOL; UNCLASSIFIED DRUG;

ARTERIAL OXYGEN SATURATION; ARTICLE; ASSISTED VENTILATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; HEMODYNAMICS; HUMAN; HYPOXEMIA; INFANT; METHEMOGLOBINEMIA; OXYGENATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; TIME; TOXICITY;

EID: 0037072098     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(02)09385-6     Document Type: Article

References (5)

1. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways
2. Inhalation of nitric oxide in acute lung injury: Results of a European multicentre study
3. Role for endothelin-1-induced superoxide and peroxynitrite production in rebound pulmonary hypertension associated with inhaled nitric oxide therapy
4. Low-level air pollution and hospital admissions for cardiac and cerebrovascular diseases in Helsinki
5. S-nitrosothiol repletion by an inhaled gas regulates pulmonary function